An open‐label clinical trial of the effects of age and gender on the pharmacodynamics, pharmacokinetics and safety of the ghrelin receptor agonist anamorelin
Publisher: John Wiley & Sons Inc
E-ISSN: 2160-7648|4|2|112-120
ISSN: 2160-763X
Source: Clinical Pharmacology In Drug Development, Vol.4, Iss.2, 2015-03, pp. : 112-120
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract